XRTX
NASDAQ · Pharmaceuticals
Xortx Therapeutics Inc
$1.91
-0.01 (-0.52%)
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,132.5% upside
Low Target
$28.32
Average Target
$42.64
High Target
$47.79
Current Price
$1.91
Current
$1.91
$1.91
Target
$42.64
$42.64
$28.32
$42.64 avg
$47.79
Scenario Analysis
Bear Case
$28.32
1,382.7%
Low target
Base Case
$42.64
+2,132.5%
Avg target
Bull Case
$47.79
+2,402.1%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$9.85
-80.6% from high
52-Week Low
$2.42
+-21.1% from low
Target vs 52W High
$42.64
+332.9% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +13.7% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.3% |
| MRK | Buy | 36 | 72% | $159.27 | +5.5% |
| PFE | Hold | 36 | 39% | $33.90 | +21.4% |
| BMY | Hold | 35 | 43% | $174.50 | +180.3% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +188.0% |